About Amber Bio
Amber Bio is a company based in San Francisco (United States) founded in 2021 by Jacob Borrajo.. Amber Bio has raised $26 million across 1 funding round from investors including Lilly, Andreessen Horowitz and Retinal Degeneration Fund. Amber Bio offers products and services including RNA Writing Platform. Amber Bio operates in a competitive market with competitors including Novartis, Catalent, Curia, Surrozen and Biotage, among others.
- Headquarter San Francisco, United States
- Founders Jacob Borrajo
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26 M (USD)
in 1 rounds
-
Latest Funding Round
$26 M (USD), Seed
Aug 03, 2023
-
Investors
Lilly
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amber Bio
Amber Bio offers a comprehensive portfolio of products and services, including RNA Writing Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables editing of thousands of genetic mutations with a single product.
Unlock access to complete
Unlock access to complete
Funding Insights of Amber Bio
Amber Bio has successfully raised a total of $26M through 1 strategic funding round. The most recent funding activity was a Seed round of $26 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $26.0M
-
First Round
First Round
(03 Aug 2023)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Seed - Amber Bio | Valuation | a16z |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amber Bio
Amber Bio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Andreessen Horowitz and Retinal Degeneration Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Investments are focused on retinal degeneration therapeutic solutions.
|
Founded Year | Domain | Location | |
|
Investments in early-stage startups are focused on by Hummingbird Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amber Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Amber Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amber Bio Comparisons
Competitors of Amber Bio
Amber Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Curia, Surrozen and Biotage, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Amber Bio
When was Amber Bio founded?
Amber Bio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Amber Bio located?
Amber Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Amber Bio?
Jacob Borrajo is the current CEO of Amber Bio. They have also founded this company.
Is Amber Bio a funded company?
Amber Bio is a funded company, having raised a total of $26M across 1 funding round to date. The company's 1st funding round was a Seed of $26M, raised on Aug 03, 2023.
What does Amber Bio do?
Amber Bio offers RNA Writing Platform while focusing on providing healthcare solutions, biopharma outsourcing, diversified, and biologics. CDMO focused on manufacturing generic drugs. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Amber Bio?
What products or services does Amber Bio offer?
Amber Bio offers RNA Writing Platform.
Who are Amber Bio's investors?
Amber Bio has 6 investors. Key investors include Lilly, Andreessen Horowitz, Retinal Degeneration Fund, Hummingbird Ventures, and Pillar VC.